Skip to content

A human trail of Saccaharum Officinalis L. wax alcohols(Policosanol) on improvement of blood cholesterol

A 8 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Saccaharum Officinalis L. wax alcohols(Policosanol) on improvement of blood cholesterol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008540
Enrollment
100
Registered
2023-06-21
Start date
2023-01-16
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : - Saccaharum Officinalis L. wax alcohols(Policosanol) group: once a day, 1 capsule once, after breakfast, for 8 weeks {450 mg/day, 20 mg/day for Saccaharum Officinalis L. wax alco

Sponsors

Wonkwang University, Gwangju Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Men and women aged 19 ~ 75 2) LDL-cholesterol 140~189 mg/dL and total cholesterol ≥ 200 mg/dL

Exclusion criteria

Exclusion criteria: 1. a person who has taken lipid lowering agent study within 6 months before the screening test. 2. BMI < 18.5 kg/m^2 or, &ge; 35 kg/m^2 3. fasting glucose level &ge; 140 mg/dL 4. a person who is taking on diabetes medication or out of control hypertension(Systolic Blood Pressure &ge;140 mmHg OR Diastolic Blood Pressure &ge;100 mmHg) 5. Subjects who are sensitive to Saccaharum Officinalis L. wax alcohols(Policosanol) 6. have a Coagulation disorder or, taking anticoagulant, antithrombotic. 7. a person who has experience in antipsychotic medication within 3 months before the screening test. 8. history of alcoholism or substance abuse 9. Pregnant or lactating women 10. fertile women without proper contraceptives 11. Participation in other human study within 3 months before the screening test.

Design outcomes

Primary

MeasureTime frame
LDL-cholesterol;Total cholesterol

Secondary

MeasureTime frame
Lipid metabolism index; Atherogenic index;Anthropometric index

Countries

Korea, Republic of

Contacts

Public ContactYoungDal Kwon

Wonkwang University, Gwangju Medical Center

exeterin@naver.com+82-62-670-6452

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026